Free Trial
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

MariMed logo
$0.16 -0.01 (-8.53%)
As of 03:58 PM Eastern

About MariMed Stock (OTCMKTS:MRMD)

Key Stats

Today's Range
$0.15
$0.18
50-Day Range
$0.07
$0.18
52-Week Range
$0.07
$0.23
Volume
1.60 million shs
Average Volume
684,826 shs
Market Capitalization
$60.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

MariMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

MRMD MarketRank™: 

MariMed scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MariMed is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MariMed is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MariMed has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about MariMed's valuation and earnings.
  • Percentage of Shares Shorted

    0.01% of the outstanding shares of MariMed have been sold short.
  • Short Interest Ratio / Days to Cover

    MariMed has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MariMed has recently increased by 111.11%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MariMed does not currently pay a dividend.

  • Dividend Growth

    MariMed does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.01% of the outstanding shares of MariMed have been sold short.
  • Short Interest Ratio / Days to Cover

    MariMed has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MariMed has recently increased by 111.11%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MariMed has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for MariMed this week, compared to 1 article on an average week.
  • Search Interest

    5 people have searched for MRMD on MarketBeat in the last 30 days.
  • MarketBeat Follows

    3 people have added MariMed to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MariMed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.99% of the stock of MariMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.18% of the stock of MariMed is held by institutions.

  • Read more about MariMed's insider trading history.
Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MRMD Stock News Headlines

MariMed Inc. (MRMD) Q2 2025 Earnings Call Transcript
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
MariMed (MRMD) Q2 EPS Jumps to Positive
MariMed Reports Second Quarter 2025 Earnings
See More Headlines

MRMD Stock Analysis - Frequently Asked Questions

MariMed's stock was trading at $0.1158 at the start of the year. Since then, MRMD stock has increased by 29.5% and is now trading at $0.15.

MariMed Inc. (OTCMKTS:MRMD) announced its quarterly earnings data on Wednesday, May, 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $37.96 million for the quarter, compared to analyst estimates of $38.33 million. MariMed had a negative net margin of 10.14% and a negative trailing twelve-month return on equity of 10.52%.
Read the conference call transcript
.

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include Canopy Growth (CGC), Innovative Industrial Properties (IIPR), NVIDIA (NVDA), Curaleaf (CURLF), Aurora Cannabis (ACB), Meta Platforms (META) and Tilray Brands (TLRY).

Company Calendar

Last Earnings
5/07/2025
Today
9/05/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MRMD
Previous Symbol
OTC:MRMD
CIK
1522767
Fax
N/A
Employees
260
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.16 million
Net Margins
-10.14%
Pretax Margin
-4.30%
Return on Equity
-10.52%
Return on Assets
-3.10%

Debt

Debt-to-Equity Ratio
1.25
Current Ratio
1.12
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$157.96 million
Price / Sales
0.39
Cash Flow
$0.02 per share
Price / Cash Flow
8.18
Book Value
$0.16 per share
Price / Book
0.99

Miscellaneous

Outstanding Shares
390,430,000
Free Float
316,291,000
Market Cap
$61.53 million
Optionable
Not Optionable
Beta
3.01
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:MRMD) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners